How much do you know about Ensidipine in Laos? This article will take you into this overseas drug!

With the popularity of targeted therapy in the field of hematological tumors, enasidenib has gradually become an important treatment option for patients with IDH2 mutant acute myeloid leukemia (AML). However, the original drug is expensive and has not yet been widely launched or reimbursed in the domestic market, causing many patients to turn their attention to overseas generic drugs, especially the version from Lucius Pharmaceutical Factory in Laos. This version of Encidipine is available in 50mg*30 tablets. The price per box is about RMB 1,000, which is far lower than the tens of thousands of RMB for the original drugs in Europe and the United States. It is highly attractive to patients with high financial pressure.

From the perspective of efficacy, Lao generic drugs are usually produced in strict accordance with the standards of the original research. Drug ingredients, dosage forms, content and bioavailability tend to be consistent. In theory, they have similar efficacy to the original research. In actual use, many patients reported that the Lao version of ensidipine performed well in controlling disease, improving blood images, and inducing differentiation, and its tolerability was comparable to the original drug. Of course, due to the lack of formal approval from the China Food and Drug Administration, this type of generic drugs has not been widely included in clinical guideline recommendations in China. Therefore, the risk and effect assessment of their use still needs to be combined with the professional judgment of clinicians.

It is worth noting that although the price of the Lao version of ensidipine is close to the people, patients need to be extremely cautious when purchasing it. They should choose a formal and qualified international drug platform or obtain it through a doctor’s recommendation to avoid buying fake drugs or substandard products. In addition, long-term use of such overseas drugs still requires regular bone marrow examinations, blood monitoring and side effects observation to ensure drug safety.

In general, the Laos generic version of ensidipine provides some patients with a more cost-effective treatment plan, but it should still be used under the guidance of a professional doctor, and treatment plans cannot be purchased or replaced without authorization. If financial conditions and disease conditions permit, it will be more secure if you can obtain original drugs or treatments with clear clinical pathways.

Reference materials:https://www.idhifa.com/